A high placebo relapse rate was also observed for patients with a baseline MADRS below median , while low escitalopram relapse rates were characteristic of patients who had achieved remission by Week @ or @ ( HR = @ ) , had a current depressive episode length below median , baseline MADRS below median ( HR = @ ) , or received @mg for @ weeks ( HR = @ ) .